CREX(CREX)
CREX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $102M | $114M |
| Low | $100M | $110M |
| High | $103M | $118M |
| EBITDA Avg | $9M | $10M |
| Low | $9M | $9M |
| High | $9M | $10M |
| EBIT Avg | $513,363 | $578,019 |
| Low | $504,654 | $557,714 |
| High | $522,634 | $596,513 |
| Net Income Avg | $-7M | $2M |
| Low | $-7M | $2M |
| High | $-6M | $2M |
| EPS Avg | $-0.62 | $0.23 |
| Low | $-0.63 | $0.22 |
| High | $-0.61 | $0.23 |
| Analysts (Rev / EPS) | 2 / 2 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $28M | $36M | $20M | $24M | $28M | $39M |
| Low | $27M | $35M | $20M | $24M | $27M | $38M |
| High | $28M | $36M | $21M | $25M | $29M | $40M |
| EBITDA Avg | $2M | $3M | $2M | $2M | $2M | $3M |
| Low | $2M | $3M | $2M | $2M | $2M | $3M |
| High | $2M | $3M | $2M | $2M | $2M | $3M |
| EBIT Avg | $140,020 | $180,824 | $103,100 | $123,622 | $143,297 | $198,755 |
| Low | $135,214 | $174,618 | $99,562 | $119,379 | $138,378 | $191,933 |
| High | $142,747 | $184,346 | $105,108 | $126,029 | $146,088 | $202,626 |
| Net Income Avg | $-422,080 | $4M | $-5M | $-3M | — | $5M |
| Low | $-1M | $4M | $-5M | $-3M | — | $5M |
| High | $115,102 | $4M | $-4M | $-3M | — | $6M |
| EPS Avg | $-0.04 | $0.39 | $-0.44 | $-0.25 | — | $0.52 |
| Low | $-0.10 | $0.37 | $-0.45 | $-0.26 | — | $0.50 |
| High | $0.01 | $0.39 | $-0.42 | $-0.24 | — | $0.53 |
| Analysts (Rev / EPS) | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |